๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Studies on the mechanism of action of cytosine arabinoside

โœ Scribed by Kufe, D. W. ;Major, P. P.


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
944 KB
Volume
10
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


We have demonstrated that Ara-C incorporates in leukemic cell DNA and that the extent of this incorporation correlates significantly with loss of clonogenic survival. This relationship between formation of (Ara-C)DNA and cytotoxicity is also obtained in the presence of modulating agents such as thymidine. Further, the (Am-C)DNA is structurally abnormal and undergoes strand scission upon exposure to alkali. We have also demonstrated that the incorporated h a -C residue serves as a poor primer terminus for further chain elongation and thereby results in inhibition of DNA synthesis. These findings provide new insights into the mechanism of action of the most effective agent in the treatment of acute myelogenous leukemia. These findings have also been extended to demonstrate that Ara-C results in the induction of leukemic cell differentiation as well as lethal cellular events.


๐Ÿ“œ SIMILAR VOLUMES


Cellular aspects of the action of cytosi
โœ Valeriote, Fred ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 984 KB

The cellular effects of Ara-C are reviewed including its S-phase sensitivity, its proliferative-dependent cytotoxicity and progression delay effects which result in unbalance growth. Both direct and indirect cytotoxic mechanisms are discussed. The impact of such cellular information on the scheduli

Studies on the mechanism of biotin actio
โœ Howard J. Schaeffer; Parmatma S. Bhargava ๐Ÿ“‚ Article ๐Ÿ“… 1962 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 194 KB ๐Ÿ‘ 1 views
Cytosine arabinoside in the management o
โœ T. S. Ganesan; M. J. Barnett; R. J. Amos; E. M. Piall; G. W. Aherne; A. Man; T. ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 254 KB

A Phase I1 study of high dose cytosine arabinoside (ara-C) with different schedules in patients with recurrent acute myelogenous leukaemia (AML) and myeloid blast crisis of chronic myeloid leukaemia has been conducted at St. Bartholomew's Hospital. Ara-C was infused continuously for seven days at a